Dr. Daniel G. Hermann, M.D.
Cardiology (Cardiovascular Disease Physician)
- Medicare participating
At a glance
- Medical school
- University of Texas Medical Branch at Galveston (2008)
- Years since graduation
- 18
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 818
Licensed in Texas since 2015, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2008Medical school: University of Texas Medical Branch at Galveston
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Cardiovascular Disease Physician primary
TX license Q4977 (first issued 2015; active) -
Internal Medicine Physician
NC license 2013-01268 - Student in an Organized Health Care Education/Training Program
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Memorial Hermann Hospital System Houston, TX
- Memorial Hermann - Texas Medical Center Houston, TX
- Memorial Hermann Memorial City Hospital Houston, TX
Medical groups
- Memorial Hermann Medical Group (762 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 818
- Services billed
- 3,409
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 497 | 471 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 492 | 465 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 331 | 142 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 320 | 314 |
| Injection, regadenoson, 0.1 mg | 188 | 44 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 133 | 111 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 125 | 123 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 117 | 115 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 115 | 98 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 105 | 102 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Atorvastatin Calcium Other prescribers in Houston, TX | 592 |
| Metoprolol Succinate Other prescribers in Houston, TX | 378 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Houston, TX | 360 |
| Losartan Potassium Other prescribers in Houston, TX | 253 |
| Amlodipine Besylate Other prescribers in Houston, TX | 246 |
| Rosuvastatin Calcium Other prescribers in Houston, TX | 243 |
| Eliquis (apixaban) Other prescribers in Houston, TX | 231 |
| Carvedilol Other prescribers in Houston, TX | 227 |
| Metoprolol Tartrate Other prescribers in Houston, TX | 185 |
| Lisinopril Other prescribers in Houston, TX | 136 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 13 companies reported 108 payments worth $6,260 in total to this clinician.
| Abbott Laboratories | $2,182 |
|---|---|
| Edwards Lifesciences Corporation | $1,021 |
| Abiomed | $947 |
| Medtronic, Inc. | $947 |
| Boston Scientific Corporation | $326 |
| Shockwave Medical, Inc | $275 |
| Amgen Inc. | $201 |
| Novartis Pharmaceuticals Corporation | $158 |
| Food and Beverage | $6,260 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.